Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis

• Main Authors: Xinsheng Wu (Author), Guohui Wu (Author), Ping Ma (Author), Rugang Wang (Author), Linghua Li (Author), Yinghui Sun (Author), Junjie Xu (Author), Yuwei Li (Author), Tong Zhang (Author), Quanmin Li (Author), Yuecheng Yang (Author), Lijing Wang (Author), Xiaoli Xin (Author), Ying Qiao (Author), Bingxue Fang (Author), Zhen Lu (Author), Xinyi Zhou (Author), Yuanyi Chen (Author), Qi Liu (Author), Gengfeng Fu (Author), Hongxia Wei (Author), Xiaojie Huang (Author), Bin Su (Author), Hui Wang (Author), Huachun Zou (Author)
• Format: Book
• Published: BMC, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background In 2003, China implemented free antiretroviral therapy (ART) for people living with HIV (PLHIV), establishing an eligibility threshold of CD4 < 200 cells/μl. Subsequently, the entry criteria were revised in 2012 (eligibility threshold: CD4 ≤ 350 cells/μl), 2014 (CD4 ≤ 500 cell...